Ivana Kacířová
- Psychiatry and Mental health top 10%
- Epilepsy research and treatment 18
- Schizophrenia research and treatment 6
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy 14
-
- Pharmacological Effects and Toxicity Studies 20
- Pharmaceutical studies and practices 9
- Nephrology top 10%
- Clinical Biochemistry top 10%
-
- Pregnancy and Medication Impact 13
-
- Antimicrobial Resistance in Staphylococcus 8
-
- Analytical Methods in Pharmaceuticals 6
Ivana Kacířová
62 papers receiving 611 citations
Peers
Comparison fields: 5 of 94
- Psychiatry and Mental health 185
- Pharmacology 162
- Pediatrics, Perinatology and Child Health 167
- Nephrology 54
- Clinical Biochemistry 49
Countries citing papers authored by Ivana Kacířová
This map shows the geographic impact of Ivana Kacířová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivana Kacířová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivana Kacířová more than expected).
Fields of papers citing papers by Ivana Kacířová
This network shows the impact of papers produced by Ivana Kacířová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivana Kacířová. The network helps show where Ivana Kacířová may publish in the future.
Co-authorship network
The 19 scholars most cited alongside Ivana Kacířová, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 7 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 2 | |
| 8 | 2023 | 5 | |
| 9 | 2021 | 11 | |
| 10 | 2021 | 8 | |
| 11 | 2021 | 2 | |
| 12 | 2021 | 6 | |
| 13 | 2021 | 6 | |
| 14 | 2021 | 2 | |
| 15 | 2020 | 3 | |
| 16 | 2016 | 4 | |
| 17 | 2016 | 4 | |
| 18 | 2013 | 23 | |
| 19 | Intoxikace venlafaxinem - využití TDM, fenotypizace a genotypizace | 2012 | 1 |
| 20 | Dávkování vankomycinu při kontinuální náhradě funkce ledvin | 2011 | 3 |
About Ivana Kacířová
Ivana Kacířová is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Pharmacology, having authored 69 papers that have together received 630 indexed citations. Recurring topics across this work include Pharmacological Effects and Toxicity Studies (20 papers), Epilepsy research and treatment (18 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers), Pregnancy and Medication Impact (13 papers), Pharmaceutical studies and practices (9 papers), Antimicrobial Resistance in Staphylococcus (8 papers), Analytical Methods in Pharmaceuticals (6 papers) and Schizophrenia research and treatment (6 papers). The work is most often cited by research in Psychiatry and Mental health (185 citations), Pharmacology (162 citations) and Pediatrics, Perinatology and Child Health (167 citations). Ivana Kacířová has collaborated with scholars based in Czechia and Germany. Frequent co-authors include Milan Grundmann, Hana Brozmanová, Naděžda Petejová, Arnošt Martínek, Karel Lemr, Karel Urbánek, David Stejskal, Zdeněk Švagera, Josef Zadražil and Marcela Káňová. Their work appears in journals such as International Journal of Molecular Sciences, Medicine and Clinica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.